Similarly, for oligodendroglioma, astrocytes, andtheir IDH1 mutant versions, the accuracies stood at 90%, 86%, and81%, respectively.26 Another work by Livermoreand group studies the ability of Raman to classify brain cancer basedon their genetic subtypes. The gene discussed is IDH1; the disease is oligodendroglioma.